Go Pro

SPDR S&P Pharmaceuticals ETF (XPH) Holdings List

SPDR S&P Pharmaceuticals ETF logo
$67.16 0.00 (0.00%)
As of 07/2/2026 04:10 PM Eastern

What stocks does XPH hold?

The SPDR S&P Pharmaceuticals ETF (XPH) top stock holdings include Definium Therapeutics, MBX Biosciences, and Atai Beckley. The top 25 XPH holdings ordered by weight make up 47.74% of the total fund. XPH is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete XPH stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 XPH Holdings

RankCompanyCurrent PriceWeightShares Held
1
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
$44.19
2.98%266,043
2
MBX Biosciences, Inc. stock logo
MBX
MBX Biosciences
$57.80
2.60%199,510
3
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
$5.19
2.15%1,635,676
4
MANE
Veradermics
$129.86
+0.1%
2.10%66,495
5
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
$17.93
2.08%461,405
6
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$49.82
2.08%167,106
7
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$18.27
2.03%459,352
8
Alumis Inc. stock logo
ALMS
Alumis
$26.50
2.03%308,218
9
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
$39.56
1.94%187,813
10
Nuvation Bio Inc. stock logo
NUVB
Nuvation Bio
$5.69
-0.3%
1.90%1,349,966
11
Ligand Pharmaceuticals Incorporated stock logo
LGND
Ligand Pharmaceuticals
$319.55
1.88%24,906
12
Liquidia Corporation stock logo
LQDA
Liquidia
$78.93
1.84%94,756
13
Harrow, Inc. stock logo
HROW
Harrow
$42.74
1.80%172,226
14
Maze Therapeutics, Inc. stock logo
MAZE
Maze Therapeutics
$31.26
1.78%251,396
15
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
$9.64
1.73%707,419
16
Amneal Pharmaceuticals, Inc. stock logo
AMRX
Amneal Pharmaceuticals
$17.15
1.73%403,580
17
Nektar Therapeutics stock logo
NKTR
Nektar Therapeutics
$71.04
1.72%108,891
18
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
$90.21
1.72%79,145
19
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$13.98
1.70%501,448
20
Indivior PLC stock logo
INDV
Indivior
$39.80
1.69%162,321
21
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$129.34
-0.2%
1.66%51,918
22
Pacira BioSciences, Inc. stock logo
PCRX
Pacira BioSciences
$25.39
1.66%263,997
23
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$24.94
-0.2%
1.65%270,346
24
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
$42.23
1.65%180,155
25
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$262.52
-0.2%
1.64%25,926

XPH Geographic Exposure

XPH's largest geographic exposure is United States at 91.5%, followed by Ireland at 3.0%.

  • United States
    91.5%
  • Ireland
    3.0%
  • Canada
    2.9%
  • Singapore
    1.6%
  • Cayman Islands
    1.0%

XPH Currency Exposure

XPH is exclusively exposed to USD.

  • USD
    100.0%

XPH Sector Exposure

XPH's largest sector exposure is Health Care at 85.2%, followed by Energy at 2.4%.

  • Health Care
    85.2%
  • Energy
    2.4%
  • Industrials
    1.1%

XPH Industry Exposure

XPH's largest industry exposure is Pharmaceuticals at 42.0%, followed by Biotechnology at 41.6%.

  • Pharmaceuticals
    42.0%
  • Biotechnology
    41.6%
  • Renewable Energy
    2.4%
  • Health Care Equipment & Supplies
    1.7%
  • Commercial Services & Supplies
    1.1%

XPH Sub-Industry Exposure

XPH's largest sub-industry exposure is Pharmaceuticals at 46.4%, followed by Biotechnology at 31.5%.

  • Pharmaceuticals
    46.4%
  • Biotechnology
    31.5%
  • Renewable Energy Equipment
    2.4%
  • Health Care Supplies
    1.7%

XPH Coupon Exposure

XPH's largest coupon exposure is 2-4 at 0.1%.

  • 2-4
    0.1%

XPH Maturity Exposure

XPH's largest maturity exposure is 20-30 at 0.1%.

  • 20-30
    0.1%

Related Companies and Tools


This page (NYSEARCA:XPH) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners